ReviewFrontiers in immunology2023

Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations.

Delphine Ammar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.